Nutra Pharma Corp (NPHC) Accounts Payables (2010 - 2026)

Nutra Pharma has disclosed Accounts Payables across 17 years of filings, most recently posting $889624.0 for Q2 2026.

• In Q2 2026, Accounts Payables rose 12.09% year-over-year to $889624.0; the TTM figure through Jun 2026 stood at $889624.0 (up 12.09% YoY), while the FY2025 annual figure was $853581.0, up 6.39% from the prior year.
• Accounts Payables came in at $889624.0 for Q2 2026 at Nutra Pharma, up from $844858.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $889624.0 in Q2 2026 to a low of $666188.0 in Q2 2022.
• Average Accounts Payables over 5 years is $789581.7, with a median of $797975.5 recorded in 2024.
• Year-over-year, Accounts Payables surged 38.59% in 2022 and slipped 8.82% in 2025.
• Over 5 years, Accounts Payables stood at $727367.0 in 2022, then climbed by 4.89% to $762955.0 in 2023, then advanced by 5.16% to $802314.0 in 2024, then climbed by 6.39% to $853581.0 in 2025, then rose by 4.22% to $889624.0 in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $889624.0 in Q2 2026, $844858.0 in Q1 2026, and $853581.0 in Q4 2025.